Literature DB >> 16837532

The extent of the collateral circulation influences the postprandial increase in portal pressure in patients with cirrhosis.

Agustín Albillos1, Rafael Bañares, Mónica González, Maria-Vega Catalina, Oscar Pastor, Rosario Gonzalez, Cristina Ripoll, Jaime Bosch.   

Abstract

BACKGROUND: In cirrhosis, repeated flares of portal pressure and collateral blood flow provoked by postprandial hyperaemia may contribute to variceal dilation and rupture. AIM: To examine the effect of the extent of the collateral circulation on the postprandial increase in portal pressure observed in cirrhosis. PATIENTS AND METHODS: The hepatic venous pressure gradient (HVPG), hepatic blood flow and azygos blood flow were measured in 64 patients with cirrhosis before and after a standard liquid meal.
RESULTS: Peak increases in HVPG (median+14.9%), hepatic blood flow (median+25.4%), and azygos blood flow (median+32.2%) occurred at 30 min after the meal. Compared with patients with marked postprandial increase in HVPG (above the median, n = 32), those showing mild (<15%, n = 32) increase in HVPG had a higher baseline azygos flow (p<0.01) and underwent a greater postprandial increase in azygos flow (p<0.02). Hepatic blood flow increased similarly in both groups. Postprandial increases in HVPG were inversely correlated (p<0.001) with both baseline azygos flow (r = -0.69) and its postprandial increase (r = -0.72). Food intake increased nitric oxide products in the azygos (p<0.01), but not in the hepatic vein. Large varices (p<0.01) and previous variceal bleeding (p<0.001) were more frequent in patients with mild increase in HVPG.
CONCLUSIONS: Postprandial hyperaemia simultaneously increases HVPG and collateral flow. The extent of the collateral circulation determines the HVPG response to food intake. Patients with extensive collateralisation show less pronounced postprandial increases in HVPG, but associated with marked flares in collateral flow. Collateral vessels preserve their ability to dilate in response to increased blood flow.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837532      PMCID: PMC1856769          DOI: 10.1136/gut.2006.095240

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

1.  Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.

Authors:  R de Franchis
Journal:  J Hepatol       Date:  2000-11       Impact factor: 25.083

2.  Effects of long-term propranolol and octreotide on postprandial hemodynamics in cirrhosis: a randomized, controlled trial.

Authors:  Julio D Vorobioff; Marcelo Gamen; David Kravetz; Eduardo Picabea; Roberto Villavicencio; Juan Bordato; Andrés Ruf; Fernando Bessone; Gustavo Romero; Jorge Palazzi; Alicia Nicora; María Passamonti; Hugo Tanno
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

3.  Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension.

Authors:  A Escorsell; J M Bordas; B Castañeda; J Llach; J C García-Pagán; J Rodés; J Bosch
Journal:  Hepatology       Date:  2000-05       Impact factor: 17.425

4.  Octreotide ameliorates the increase in collateral blood flow during postprandial hyperemia in portal hypertensive rats.

Authors:  Shin Sakurabayashi; Kwang Cheol Koh; Lisa Chen; Roberto J Groszmann
Journal:  J Hepatol       Date:  2002-04       Impact factor: 25.083

5.  Endothelin-1 induces vasoconstriction on portal-systemic collaterals of portal hypertensive rats.

Authors:  C C Chan; S S Wang; F Y Lee; F Y Chang; H C Lin; C J Chu; C T Chen; H C Huang; S D Lee
Journal:  Hepatology       Date:  2001-04       Impact factor: 17.425

6.  Low doses of isosorbide mononitrate attenuate the postprandial increase in portal pressure in patients with cirrhosis.

Authors:  Lia Bellis; Annalisa Berzigotti; Juan G Abraldes; Eduardo Moitinho; Juan C García-Pagán; Jaime Bosch; Juan Rodés
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

7.  A liver-specific nitric oxide donor improves the intra-hepatic vascular response to both portal blood flow increase and methoxamine in cirrhotic rats.

Authors:  Mauricio R Loureiro-Silva; Gregory W Cadelina; Yasuko Iwakiri; Roberto J Groszmann
Journal:  J Hepatol       Date:  2003-12       Impact factor: 25.083

8.  NCX-1000, a nitric oxide-releasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver.

Authors:  Stefano Fiorucci; Elisabetta Antonelli; Vincenzo Brancaleone; Laura Sanpaolo; Stefano Orlandi; Eleonora Distrutti; Giancarlo Acuto; Carlo Clerici; Monia Baldoni; Piero Del Soldato; Antonio Morelli
Journal:  J Hepatol       Date:  2003-12       Impact factor: 25.083

9.  Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

Authors:  Mercedes Fernandez; Francesco Vizzutti; Juan Carlos Garcia-Pagan; Juan Rodes; Jaime Bosch
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

10.  Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.

Authors:  Carmen Zafra; Juan G Abraldes; Juan Turnes; Annalisa Berzigotti; Mercedes Fernández; Juan C Garca-Pagán; Juan Rodés; Jaime Bosch
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

View more
  11 in total

Review 1.  Current concepts on the role of nitric oxide in portal hypertension.

Authors:  Liang Shuo Hu; Jacob George; Jian Hua Wang
Journal:  World J Gastroenterol       Date:  2013-03-21       Impact factor: 5.742

2.  Dynamic postprandial hepatic stiffness augmentation assessed with MR elastography in patients with chronic liver disease.

Authors:  Meng Yin; Jayant A Talwalkar; Kevin J Glaser; Sudhakar K Venkatesh; Jun Chen; Armando Manduca; Richard L Ehman
Journal:  AJR Am J Roentgenol       Date:  2011-07       Impact factor: 3.959

Review 3.  Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

4.  Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Peter W Angus; Sanjay Saran Baijal; Yogesh Kumar Chawla; Radha Krishna Dhiman; H Janaka de Silva; Saeed Hamid; Shozo Hirota; Ming-Chih Hou; Wasim Jafri; Mobin Khan; Laurentius A Lesmana; Hock F Lui; Veena Malhotra; Hitoshi Maruyama; Debendranath Guha Mazumder; Masao Omata; Ujjal Poddar; Amrinder S Puri; Praveen Sharma; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Hasnain Ali Shah; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2008-09-05       Impact factor: 6.047

Review 5.  Nonendoscopic management strategies for acute esophagogastric variceal bleeding.

Authors:  Sanjaya K Satapathy; Arun J Sanyal
Journal:  Gastroenterol Clin North Am       Date:  2014-09-27       Impact factor: 3.806

Review 6.  Cirrhotic Multiorgan Syndrome.

Authors:  Søren Møller; Flemming Bendtsen
Journal:  Dig Dis Sci       Date:  2015-06-26       Impact factor: 3.199

7.  Role of echo Doppler ultrasonography in the evaluation of postprandial hyperemia in cirrhotic patients.

Authors:  Osman Ozdogan; Huseyin Atalay; Cagatay Cimsit; Veysel Tahan; Sena Tokay; Adnan Giral; Nese Imeryuz; Feyyaz Baltacioglu; Davut Tuney; Canan Erzen; Nurdan Tozun
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

8.  Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension.

Authors:  Annalisa Berzigotti; Andrea De Gottardi; Ranka Vukotic; Sith Siramolpiwat; Juan G Abraldes; Juan Carlos García-Pagan; Jaime Bosch
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

9.  Portal Venous Flow Is Increased by Jejunal but Not Colonic Hydrogen Sulfide in a Nitric Oxide-Dependent Fashion in Rats.

Authors:  Aleksandr Birg; Henry C Lin; Nancy Kanagy
Journal:  Dig Dis Sci       Date:  2020-09-11       Impact factor: 3.487

10.  Changes in portal blood flow and liver functions in cirrhotics during Ramadan fasting in the summer; a pilot study.

Authors:  Salem Y Mohamed; Mohamed H Emara; Hala Im Hussien; Hany M Elsadek
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.